The interpretation of cytogenetic abnormalities in multiple myeloma mm is often a challenging task. Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. The american cancer society s estimates for multiple myeloma in the united states for 2020 are. Multiple myeloma represents 2% of all new cancer diagnoses in the united. An approach to the diagnosis and management of multiple myeloma. Pdf on nov 29, 2005, alastair smith and others published guidelines on the diagnosis and management of multiple myeloma 2005 find. Epidemiology 2000 new canadian patient with myeloma in 2007 207 new patients in bc in 2005 169 patients died of myeloma in 2004 500 patients with myeloma in bc. A cancerous or malignant plasma cell is called a myeloma cell. Multiple myeloma is a cancer of certain cells of the bone marrow called plasma cells. It presents most frequently as bone pain and patients tend to become dehydrated and may develop renal failure. Solitary plasmacytoma is a mass of myeloma cells that involves only 1 site in the bone or, less commonly, other organs, such as in the upper respiratory tract, including the. The initial treatment for multiple myeloma may be either. The disease is called multiple myeloma because it affects many bones.
Multiple myeloma mm is a neoplastic plasma cell disorder characterized by clonal proliferation of malignant plasma cells in the bone marrow and usually monoclonal protein in the blood andor urine. A change in the bone marrow or a mutation in a plasma cells dna. Watch the full interview with multiple myeloma patient ginny johnston in 2016, the american cancer society estimates that 30,330 new multiple myeloma cases will be diagnosed and 12,650 cancer deaths due to multiple myeloma would occur. Malignanat b cell lymphoproliferative disorder of the marrow with plasma cell predominating. Myeloma can cause a range of symptoms because of its effect on the bones, bone marrow, blood, urine and kidneys.
Myeloma is usually called multiple myeloma because most people 90% or more have multiple bone lesions when diagnosed or lesions develop over the course of the illness. If myeloma cells collect in only one bone, the single mass is called a plasmacytoma. Median survival is about three years, but some patients have a life expectancy of 10 years. In 2015, an estimated 28,850 new cases of multiple myeloma were. Myeloma is a type of cancer that develops from plasma cells in the bone marrow. Multiple myeloma dr harpreet singh bhatia dmch, ludhiana,punjab 2. Pdf multiple myeloma mm is a plasma cell dyscrasia that accounts for 10% of haematological malignancies. Multiple myeloma is a form of cancer that begins in plasma cells and affects multiple bones. Edited and written by a multidisciplinary group of recognized authorities from the mayo clinic, it presents clear guidelines on diagnosis and therapy and covers all aspects of multiple myeloma, from. Not only do you need to listen carefully to your doctors, take the required drugs, go through the required treatments and eat well you knew i will tell you that, but you need to exercise too. Multiple myeloma features abnormal proliferation of plasma cells in the bone marrow, destructive bone lesions, and the production of abnormal proteins, specifically antibodies. Management of multiple myeloma linkedin slideshare. Edited and written by a multidisciplinary group of recognized authorities from the mayo clinic, it presents clear guidelines on diagnosis and therapy and covers all aspects of multiple myeloma, from molecular classification and diagnosis, to risk. Patients with multiple myeloma mm often deal with short and longterm side effects of the treatment and disease sequelae.
Multiple myeloma mm, also known as symptomatic plasma cell myeloma, is a plasma cell malignancy. Why myeloma patients need exercise the myeloma crowd. P director of the h ematology laboratory tufts, boston city hospital. Multiple myeloma is a disease in which a neoplastic proliferation of plasma cells produces a monoclonal immunoglobulin.
Multiple myeloma is a cancer of the bone marrow plasma cells. The international myeloma foundation can provide further support for myeloma patients. Multiple myeloma is a malignant plasma cell disorder in the bone marrow, which produce a monoclonal immunoglobulin paraprotein or mprotein. Public health service national cancer institute fellow in iiematology, hematology. Multiple myeloma mm is an aggressive malignant neoplasm of plasma cells that accumulates in the bone marrow and contributes to approximately 15 percent of all hematologic malignancies. When multiple myeloma is suspected clinically, patients should be tested for the presence of m proteins using a combination of tests that should include a serum protein electrophoresis spep, serum immunofixation, and the serum flc assay. Clinical professor of medicine, tufts university medical school. In the united states, the lifetime risk of getting multiple myeloma is 1 in 2 0. Multiple myeloma is an evolving disease state, and amgen plans several substantive updates to the content of this site in the coming months. However, different people with myeloma can have different symptoms, and most will only have one or two symptoms. Criteria for the classification monoclonal gammopathies, multiple myeloma and related disorders.
It has to be distinguished from a igm secreting lymphoid mgus, a precursor phase of chronic. Treatment of multiple myeloma focuses on decreasing the severity of symptoms with medications, stem cell transplants, bisphosphonate therapy, platelet transfusions. Multiple myeloma is the most common type of plasma cell tumor. Oct 27, 2017 multiple myeloma is a type of cancer that targets the plasma cells in bone marrow. Plain films revealed a lytic lesion in his left proximal femur as well as additional smaller lytic lesions.
Hyperdiploid myeloma is characterized by multiple trisomies of chromosomes 3, 5, 7, 9 11, 15, 19 and 21, and lacks recurrent immunoglobulin gene translocations. The first of these drugs to be developed, thalidomide, caused severe birth defects when taken during pregnancy. Three immunomodulating agents are used to treat multiple myeloma. Multiple myeloma objectives and mgus of hematopoietic stem. Common manifestations include lytic lesions in bones causing pain, andor fractures, renal insufficiency, hypercalcemia, anemia, and recurrent infections. First described in 1848, mm is characterized by a proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein m protein. Management of multiple myeloma in the newly diagnosed patient. The novel therapiesthalidomide, bortezomib, and lenalidomidehave resulted in improved survival rates. Patients may present with nonspecific symptoms, such as nausea, vom iting, malaise, weakness, recurrent infections, or weight loss. These clonal plasma cells proliferate in the bone marrow and often result in extensive skeletal destruction with osteolytic lesions, osteopenia, andor pathologic fractures. Plasma cells come from b lymphocytes, and produce antibodies immunoglobulins. Multiple myeloma mm is a disease that is primarily treated by hematologists. The following are a few of the topics that the imwg covers.
Multiple myeloma objectives and mgus of hematopoietic. Key statistics about multiple myeloma multiple myeloma is a relatively uncommon cancer. Why myeloma patients need exercise register for muscles for myeloma by danny parker you need to exercise. Multiple myeloma mm belongs to the group of plasma cell neoplasms table 1.
As bone marrow is found in multiple areas of the body e. This guideline covers the diagnosing and managing of myeloma including smouldering myeloma and primary plasma cell leukaemia in people aged 16 and over. These patients typically fulfill the diagnostic criteria for multiple myeloma and have evidence of amyloid light chain deposition confirmed by congo red staining. This is a comprehensive, state of theart guide to the diagnosis, treatment, and biology of multiple myeloma and related plasma disorders. The dna of plasma cells becomes damaged and this causes the cells to become cancerous.
The management of multiple myeloma from the hematology laboratory rufts, boston city hospital, boston, massachusetts william c. Multiple myeloma is divided into two distinct genetic subtypes based on chromosome content. This is a comprehensive, stateoftheart guide to the diagnosis, treatment, and biology of multiple myeloma and related plasma disorders. This emedtv article describes this condition in detail and includes information about its symptoms, diagnosis, and treatment. The changing paradigm highdose chemotherapy and stem cell transplantation todd zimmerman, md university of chicago medical center.
Current status relapsed disease transient response to therapy survival years diagnosis survival 35 yrs survival multiple myeloma is an evolving disease state, and amgen plans several substantive updates to the content of this site in the coming months. Mm is characterized by several cytogenetic abnormalities that. Bone disease and renal failure are the main cause of morbidity. Please subscribe to be notified as these updates become available. Myeloma associated al amyloidosis is reported in 1230% of multiple myeloma patients. Multiple myeloma is a plasma cell neoplasm that is characterized by a single clone of plasma cells producing a monoclonal protein mprotein. Both nonintensive and intensive treatments involve taking a combination of antimyeloma medicines. In may 20, the international myeloma working group imwg released practice guidelines for the management of multiple myelomarelated. Virtually every case of mm is preceded by a premalignant pc tumor called monoclonal gammopathy of undetermined significance mgus 6, 7 that, like mm, produces a typical mspike almost always nonigm by spep or free light chain in the urine. Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. The imf s reach extends to more than 525,000 members in 140 countries worldwide. Reasons for inadequately managed symptoms are multifactorial e.
Amyloidosis should be suspected in the presence of. Multiple myeloma is slightly more common in men than in women and the median age at the time of diagnosis is about 65 years. A single mass of myeloma cells is called a solitary plasmacytoma, which is most often found in the bones but can also be found in soft tissue called an extramedullary plasmacytoma. Leukemia 2006 w erratum 2007 mprotein in serum andor urine or abnormal flc ratio. Multiple myeloma is a cancer of the plasma cells in the bone marrow seek medical care for unexplained pain, nausea, vomiting, weight loss, vision problems, or chronic tingling or numbness there is no cure for multiple myeloma. Oct 30, 2015 the interpretation of cytogenetic abnormalities in multiple myeloma mm is often a challenging task. Mm is characterized by several cytogenetic abnormalities that occur at various time points in. Pdf an approach to the diagnosis and management of multiple. It is characterised by a clonal population of bone marrow plasma cells which secrete a monoclonal paraprotein or an immunoglobulin free light chain flc figure 1a, b. It is synonymous with myeloma and plasma cell myeloma. Abstract multiple myeloma accounts for approximately 10% of. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications. The imf is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure through.
Multiple myeloma is a type of cancer that targets the plasma cells in bone marrow. Because the other immunomodulating agents are related to thalidomide, theres concern that they could also cause birth defects. Myeloma management and treatment guidelines summaries. Multiple myeloma mm is characterized by the neoplastic proliferation of clonal plasma cells producing a monoclonal immunoglobulin. Pdf guidelines on the diagnosis and management of multiple. The contents of diagnosis and management of multiple myeloma are listed below. Multiple myeloma early detection, diagnosis, and staging. Interpretation of cytogenetic results in multiple myeloma for. Multiple myeloma early detection, diagnosis, and staging cancer. Multiple myeloma occurs in over 2000 new patients in england and wales each year.
This patientspecific mprotein can be detected in the serum or in the urine as free light chains. Patients with indolent relapse can be treated with 2drug or 3drug combinations. In asymptomatic patients, multiple myeloma is most likely to be identified through laboratory abnormalities such as hypercalcemia, anemia, or proteinuria. Imwg publishes recommendations for the diagnosis and management of myelomarelated renal impairment. Guidelines for the diagnosis and management of multiple. Plasma cells make antibodies against infectious agents such as viruses and bacteria. Management of multiple myeloma dr saqib ahmad shah pg department of radiation oncology skims moderator. With new and upcoming information about myeloma and its treatments, the international myeloma working groups summaries clarify upcoming data in an easier way. Cancer society, the total new cases of multiple myeloma diagnosed annually in canada are estimated at 2,550 1,450 men and 1,100 women, representing an incidence of 5 in 100,000 people. Myeloma is a cancer of plasma cells that begins in the bone marrow.
Monitor for multiple myeloma symptoms and m protein serum and urine every six to 12 months in patients with monoclonal gammopathy of undetermined significance, and every three to four months in. The imwgs research on multiple myeloma studies its causes, how to stage the disease, and how to achieve remission. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. Click plasmacytoma for more information about this type of plasma cell tumor.
1260 1141 814 892 1111 891 435 515 430 433 1339 283 517 645 1086 68 1527 883 499 668 602 1649 804 531 157 1357 1078 470 1631 1007 912 183 606 849 1281 230 281 235 510 785 252 381 25